Streptolysin 0 is one of the numerous exotoxins secreted by the streptococcus of Group A. The best known property of this toxin is the haemolytic effect exerted on mammalian red cells. Haemolysis only occurs when the toxin is in the reduced form. Streptolysin I in the oxidized form is haemolytically inactive, but can be activated by the addition of reducing agents such as sulphydryl compounds.Streptolysin 0 is immunologically antigenic, and a high proportion of patients with streptococcal infection show a strong antibody response during convalescence. Administration of streptolysin to animals-for example, rabbits-is regularly followed by synthesis of specific antibody; and both the oxidized and reduced forms combine with specific antibody.When injected intravenously in adequate doses, streptolysin 0 produces death in most laboratory animals. Research by Kellner, Bernheimer, Carlson & Freeman (1956) and by Halbert, Bircher & Dale (1961) has shown that the lethal effect of streptolysin may be attributed to its toxic action on the heart. The object of the present investigation was to analyse with different technical procedures the modalities and the mechanism of the cardiotoxic effects of streptolysin 0.
METHODSStreptolysin 0 has not been obtained in pure form. In these experiments crude or partially purified preparations of streptolysin of different origins and greatly varying haemolytic activity were used. A minimal haemolytic dose of streptolysin (MHD5O) is defined as the quantity of streptolysin causing lysis of 50% of the fresh rabbit red cells contained in 0.5 ml. of a standardized buffered suspension in 45 min at 37°C. It